Akums Drugs and Pharmaceuticals shares jumped more than 4% after the company announced that it received exclusive rights to develop and market Triple Hair Inc.’s innovative products in India.
The deal offers Akums exclusive access to Triple Hair’s intellectual property for product development and commercialization in the Indian market.
Shares of Akums Drugs opened at ₹880.60, experiencing notable volatility throughout the trading session. The stock reached a day high of ₹929.10 and a low of ₹870.05. Over the past year, the company’s shares have ranged from a low of ₹725.00 to a high of ₹1,175.90, reflecting the market’s fluctuating sentiment.
As of 11:07 am, Akums Drugs shares were trading 3.68% higher at Rs 913.00 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
